pI: 5.1407 |
Length (AA): 244 |
MW (Da): 27142 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
11 | 184 | 1wlj (A) | 6 | 177 | 25.00 | 0 | 0.99 | 1 | -0.36 |
19 | 175 | 1wlj (A) | 15 | 168 | 31.00 | 0.0000011 | 1 | 0.93 | -0.13 |
1 | 201 | 4q8h (A) | 911 | 1111 | 47.00 | 0.0000000094 | 1 | 1.31757 | 0.28 |
3 | 192 | 4czw (A) | 881 | 1093 | 45.00 | 0.00000051 | 1 | 1.34849 | -0.68 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | metacyclic. | Smircich P |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | epimastigote. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_128883)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_III004920 | exonuclease family protein |
Brugia malayi | Bm1_20810 | CG8232-PA |
Candida albicans | CaO19.4764 | Component of Pab1p-stimulated poly(A) ribonuclease |
Candida albicans | CaO19.12228 | Component of Pab1p-stimulated poly(A) ribonuclease |
Caenorhabditis elegans | CELE_F31E3.4 | Protein PANL-2 |
Dictyostelium discoideum | DDB_G0269694 | WD40-like domain-containing protein |
Drosophila melanogaster | Dmel_CG8232 | PAN2 ortholog (S. cerevisiae) |
Echinococcus granulosus | EgrG_000610700 | PAB dependent polyA specific ribonuclease |
Echinococcus multilocularis | EmuJ_000610700 | PAB dependent poly(A) specific ribonuclease |
Homo sapiens | ENSG00000135473 | PAN2 poly(A) specific ribonuclease subunit |
Leishmania braziliensis | LbrM.30.0260 | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative |
Leishmania donovani | LdBPK_300250.1 | ubiquitin hydrolase, putative |
Leishmania infantum | LinJ.30.0250 | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative |
Leishmania major | LmjF.30.0250 | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative |
Leishmania mexicana | LmxM.29.0250 | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative |
Loa Loa (eye worm) | LOAG_00636 | hypothetical protein |
Mus musculus | ENSMUSG00000005682 | PAN2 polyA specific ribonuclease subunit homolog (S. cerevisiae) |
Neospora caninum | NCLIV_032340 | PAB-dependent poly(A)-specific ribonuclease subunit PAN2, related |
Saccharomyces cerevisiae | YGL094C | Pan2p |
Schistosoma japonicum | Sjp_0001560 | ko:K01072 ubiquitin thiolesterase [EC3.1.2.15], putative |
Schistosoma mansoni | Smp_130800 | ubiquitin specific protease 52 / poly(A) ribonuclease subunit pan2 |
Schmidtea mediterranea | mk4.004150.00 | |
Trypanosoma brucei gambiense | Tbg972.6.1360 | ubiquitin hydrolase, putative |
Trypanosoma brucei | Tb11.v5.0553 | ubiquitin hydrolase, putative |
Trypanosoma congolense | TcIL3000_6_1240 | ubiquitin hydrolase, putative |
Trypanosoma cruzi | TcCLB.507017.120 | ubiquitin hydrolase, putative |
Trypanosoma cruzi | TcCLB.505807.270 | ubiquitin hydrolase, putative |
Toxoplasma gondii | TGME49_232360 | exonuclease |
Theileria parva | TP02_0456 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_232360 | Toxoplasma gondii | Essentiality uncertain | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Leishmania major | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative | Compounds | References |